PMID: 25331030 Sigalos JT, Pastuszak AW
Notably, complaints about side effects (e.g., nausea, headaches) were below 2%and almost exclusively linked to exceeding recommended dosage or pre-existing sensitivity to copper
ECs expressing higher levels of venous markers, such as Nrp2, Madcam1, Aplnr and Nr2f2 (Coup-TFII) , can be seen on the left side of the UMAP plot, subdivided into proliferative (G2/M and S phase) and two non-proliferative groups (Venous EC1 and Venous EC2)
Current clinical evidence suggests minimal transfer of semaglutide and tirzepatide into breast milk, yet many healthcare providers remain cautious
Patients in Scotland, Wales, and Northern Ireland should note that medicines are assessed separately by the Scottish Medicines Consortium (SMC) , All Wales Medicines Strategy Group (AWMSG) , and the Department of Health Northern Ireland , respectively, meaning availability may differ across the devolved nations